STK11 and cancer: Lastly, resting mast cells demonstrated a strong positive correlation with PEBP1/STK11 co-expression of in multiple cancers, including hepatocellular carcinoma (LIHC), KICH, KIRC, BRCA, PRAD, LUAD, MESO, THCA, and SARC.